English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 开放获取期刊获得更多读者和引用
700 种期刊 和 15,000,000 名读者 每份期刊 获得 25,000 多名读者
抽象的
Factors Associated with Mortality Outcomes in Neonatal Septicemia in Srinagarind Hospital, Thailand
Zarghoon Tareen, Junya Jirapradittha, Chukiat Sirivichayakul and Watcharee Chokejindachai
Background: Neonatal Septicemia is a major cause of mortality and morbidity in newborns both in developed and developing countries.
Objective: The objective of this study was to determine the risk factors for mortality in neonatal septicemia
Materials and Methods: This retrospective case-control study was conducted in Srinagarind Hospital, Khon Kaen, Thailand. The study considered the demographics, laboratory results, and clinical features for a total of 133 patients during the period May 2005- September 2010. Thirty four out of these patients died from their condition.
Results: Investigation of neonatal demographics found that low Apgar scores in 1 minute (OR 12.237, P<0.001) and 5 min (OR 13.143, P<0.001), VLBW (OR 5.312, P<0.001), EOS (3.749, P<0.001), prematurity (2.723, P<0.01), and out born delivery (6.253, P<0.001), were all significantly associated with fatality. Laboratory results showed that hyperglycemia (OR 6.213, P<0.001) and thrombocytopenia (3.853, P<0.002), were significant contributors to fatality. Among all clinical features, lethargy (14.667, P<0.001), apnea (OR 13.160, P<0.001), poor feeding (OR 7.807, P<0.001), hypothermia (OR 4.807, P<0.001) and jaundice (OR4.769<P0.007), were significantly associated with fatality. Gram-negative bacteria were frequently isolated from dead septicemic neonates. E. coli was the most common bacteria isolated from dead septicemic neonates (18.2%), followed by Klebsiella spp. (15.9%), Enterobacter spp. (15.9%), Acinetobacter spp. (13.6%) and Pseudomonas spp. (11.3%).
Conclusion: Early detection and management of these associated factors are necessary to prevent severe and life threatening complications and death in neonatal septicemia. Strict infection control measures remain the mainstay in the management of the multidrug resistant bacterial infections in neonates.